M Meyran
- Molecular Medicine top 2%
- Epidemiology
- Pharmacology top 10%
- Infectious Diseases
- Endocrinology top 5%
- Topics
- Antibiotic Resistance in Bacteria (29 papers)Antibiotic Use and Resistance (22 papers)Antibiotics Pharmacokinetics and Efficacy (22 papers)
- Journals
- Journal of Clinical MicrobiologyAntimicrobial Agents and ChemotherapyJournal of Antimicrobial Chemotherapy
- Partner nations
- FranceUnited Kingdom
In The Last Decade
M Meyran
58 papers receiving 368 citations
Peers
Comparison fields: 5 of 63
- Molecular Medicine 229
- Epidemiology 136
- Pharmacology 108
- Infectious Diseases 104
- Endocrinology 76
Countries citing papers authored by M Meyran
This map shows the geographic impact of M Meyran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Meyran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Meyran more than expected).
Fields of papers citing papers by M Meyran
This network shows the impact of papers produced by M Meyran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Meyran. The network helps show where M Meyran may publish in the future.
Co-authorship network of co-authors of M Meyran
This figure shows the co-authorship network connecting the top 25 collaborators of M Meyran. A scholar is included among the top collaborators of M Meyran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Meyran. M Meyran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [New concepts in epidemiological surveillance in French army]. | 4 |
| 2 | Évaluation de l’efficacité de la stratégie de vaccination systématique antiméningococcique chez les appelés de l’armée française | 4 |
| 3 | [Antibiotic sensitivity of aerobic gram-negative bacilli isolated from severe infections in 1992: results of a French multicenter study. Groupe d'Etude d'Infections à bacilles à Gram Négatif (GEIGN)]. | 5 |
| 4 | 3 | |
| 5 | [Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae]. | 4 |
| 6 | 1 | |
| 7 | [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum]. | 2 |
| 8 | [Determination of the susceptibility of staphylococci and enterococci to plycopeptides by the E-test method]. | 1 |
| 9 | [Antibiotic sensitivity of 140 strains of Shigella isolated in Djibouti]. | 6 |
| 10 | 26 | |
| 11 | 3 | |
| 12 | [Skin manifestations of bilharziasis. Apropos of 24 case reports in Mali]. | 5 |
| 13 | 0 | |
| 14 | [The frequency of isolating urinary infection germs at a community practice and their sensitivity to various antibiotics]. | 8 |
| 15 | [Characteristics of penicillinase-producing strains of Neisseria gonorrhoeae isolated in France, 1979-1986]. | 2 |
| 16 | 9 | |
| 17 | [Distribution of constituent beta-lactamases in Pseudomonas aeruginosa]. | 14 |
| 18 | [Polyarthritis in anisakiasis. 1st case]. | 7 |
| 19 | [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli]. | 1 |
| 20 | Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. | 26 |
About M Meyran
M Meyran is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 63 papers that have together received 414 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (29 papers), Antibiotic Use and Resistance (22 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). The work is most often cited by research in Molecular Medicine (229 citations), Applied Microbiology and Biotechnology (43 citations) and Endocrinology (76 citations). M Meyran has collaborated with scholars based in France and United Kingdom. Frequent co-authors include A Thabaut, D. Sirot, A.L. Courtieu, F. W. Goldstein, C J Soussy, Chantal Morel, J Lemozy, M.O. Husson, A. Philippon and Roger Labia. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.